That long half-life, which is about one week, means that there arent any noteworthy side effects to stopping the medication
Patients who are interested in accessing retatrutide before potential approval may wish to explore whether they are eligible for clinical trial participation
& Adams, P
In: Walker HK, Hall WD, Hurst JW, editors
J Clin Invest 133(3):e167952 Kusminski CM, Perez-Tilve D, Mller TD, DiMarchi RD, Tschp MH, Scherer PE (2024) Transforming obesity: The advancement of multi-receptor drugs
A required route of administration due to unique medical needs. However, adding non-essential ingredients like B12, L-carnitine and other non-tested ingredients, does not qualify as a documented clinical difference